Valsartan/Cilnidipine

缬沙坦/西尼地平

Report date: 2022/01/14 13:23:58

Base Information

Drug NameValsartan/Cilnidipine
Drug Alias Name缬沙坦西尼地平Cilnidipine and Valsartan缬沙坦/西尼地平复方Valsartan-Cilnidipine mixtValsartan and Cilnidipine +[15] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockers
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2014/03/24
Country/TerritoryJapan
CombinationsYes ValsartanCilnidipine
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEa PharmaMochda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09D
Related LinksKEGG